Clinical Trials for All Sites

< Back

NCICOVID

NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study (NCT04387656)

The purpose of this study is to collect blood samples, information, and medical images from patients who are being treated for cancer and have COVID-19. Researchers will use these blood samples, information, and medical images to answer the following questions: How does COVID-19 affect the outcomes of people undergoing cancer treatment? How does having cancer affect COVID-19?

Click Here for more information

Principle Investigator: James Lee, M.D.

 

Contacts for Participation in Clinical Trials:

Virtua Samson Cancer Center
Theresa Carducci, MSN, RN, BA, CCRP
Protocol Coordinator, Cancer Registry & Research
(856) 206-4721
tcarducc@virtua.org

Voorhees
Karen Goldsmith, BSN, RN
Protocol Coordinator
(856) 247-7395
kgoldsmith@virtua.org

Maria Jenkins, CCRP
Clinical Research Coordinator
(856) 247-7396
mdjenkins@virtua.org